Investor · St. Louis, MO

Rajesh J. Devraj

Open Rajesh in the network graph →

Filings

29

SEC Form D

Connections

67

co-filers

Capital

$1.9M

across filings

Active

Sep 2014

to Sep 2023

Most-connected co-filers (67)

Albert Hummel · Aliso Viejo, CA12 shared Mara Isaacs · Princeton, NJ10 shared Bold Capital, Llc · Kalamazoo, MI10 shared Howard Mergelkamp · Aliso Viejo, CA10 shared Charles A. Bolten · St. Louis, MO8 shared Black Hills Capital, LLC · Los Angeles, CA6 shared Robert C. Trask · Los Angeles, CA6 shared Robert W. Karr · St. Louis, MO6 shared John J. Talley · St. Louis, MO4 shared Scott D. Macdonald · Toronto, Ontario, Canada4 shared Derk E. Seabold · Kalamazoo, MI4 shared Bold Capital, Llc · Kalamazoo, MI4 shared Robert Beardsley · UNIVERSITY CITY, MO4 shared Elizabeth W. Cermak · San Ramon, CA4 shared Thomas P. Cirrito · St. Louis, MO4 shared Diego D. De La Torre De La Piedra · Vancouver, British Columbia, Canada4 shared George H. Capps, Ii · St. Louis, MO4 shared Michael W. Yeadon · St. Louis, MO4 shared Robert J. Calcaterra · St. Louis, MO4 shared David W. Griggs · St. Louis, MO4 shared Bobby W. Sandage, Jr · SAINT LOUIS, MO3 shared Tom Rogat · Beachwood, OH2 shared Paul J. Pitts · Boston, MA2 shared Eduardo J. Martinez · St. Louis, MO2 shared

Recent filings (29)

Black Hills Capital Investors, LLCSep 2023 · 5 co-filers$400.0M Black Hills Capital Investors, LLCSep 2022 · 5 co-filers$400.0M Black Hills Capital Investors, LLCSep 2021 · 5 co-filers$400.0M Black Hills Capital Investors, LLCSep 2020 · 5 co-filers$400.0M Black Hills Capital Investors, LLCSep 2019 · 3 co-filers$400.0M Black Hills Capital Investors, LLCSep 2018 · 3 co-filers$400.0M Black Hills Capital Investors, LLCSep 2017 · 3 co-filers$400.0M Indalo Therapeutics, Inc.Aug 2017 · 5 co-filers$26.0M Bold Partners LPMar 2017 · 3 co-filers Euclises Pharmaceuticals, Inc.Dec 2016 · 19 co-filers$2.7M Adjuvance Technologies Inc.Nov 2016 · 17 co-filers$7.0M Black Hills Capital Investors, LLCSep 2016 · 5 co-filers$400.0M Bold Partners LPApr 2016 · 3 co-filers Antegrin Therapeutics, Inc.Oct 2015 · 19 co-filers$596K Antegrin Therapeutics, Inc.Oct 2015 · 19 co-filers$600K Euclises Pharmaceuticals, Inc.Oct 2015 · 19 co-filers$663K Euclises Pharmaceuticals, Inc.Oct 2015 · 18 co-filers$1.9M Adjuvance Technologies Inc.Sep 2015 · 19 co-filers$7.0M Black Hills Capital Investors, LLCSep 2015 · 5 co-filers$400.0M Bold Partners LPFeb 2015 · 3 co-filers Black Hills Capital Investors, LLCSep 2014 · 3 co-filers$400.0M Bold Partners LPFeb 2014 · 3 co-filers Euclises Pharmaceuticals, Inc.Jan 2014 · 16 co-filers$1.4M Bold Partners LPFeb 2013 · 1 co-filer Bold Partners LPFeb 2012 · 1 co-filer

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Rajesh in the interactive graph →